349 related articles for article (PubMed ID: 30351860)
21. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
22. A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.
Bosch M; Akhter A; Chen BE; Mansoor A; Lebrun D; Good D; Crump M; Shepherd L; Scott DW; Stewart DA
Haematologica; 2018 Feb; 103(2):288-296. PubMed ID: 29097500
[TBL] [Abstract][Full Text] [Related]
23. Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases.
Magnoli F; Bernasconi B; Vivian L; Proserpio I; Pinotti G; Campiotti L; Mazzucchelli L; Sessa F; Tibiletti MG; Uccella S
Cancer Genet; 2018 Dec; 228-229():28-40. PubMed ID: 30553470
[TBL] [Abstract][Full Text] [Related]
24. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Shen Y; Wang L; Ou J; Wang B; Cen X
Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
[No Abstract] [Full Text] [Related]
25. [Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma].
Min DL; Xia HL; Zhou XY; Sun MH; Yang WT; Zhang TM; Zheng AH; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):327-31. PubMed ID: 16185497
[TBL] [Abstract][Full Text] [Related]
26. Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.
Horn H; Ziepert M; Wartenberg M; Staiger AM; Barth TF; Bernd HW; Feller AC; Klapper W; Stuhlmann-Laeisz C; Hummel M; Stein H; Lenze D; Hartmann S; Hansmann ML; Möller P; Cogliatti S; Pfreundschuh M; Trümper L; Loeffler M; Glass B; Schmitz N; Ott G; Rosenwald A;
Leukemia; 2015 Jul; 29(7):1564-70. PubMed ID: 25687653
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis and differential diagnosis of large B-cell lymphoma with IRF4 rearrangement].
Luo D; Xiang CX; Ma DS; Liu GZ; Fan MT; Wang YB; Zhao J; Yuan YQ; Shen QQ; Liu XY; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):563-569. PubMed ID: 38825901
[No Abstract] [Full Text] [Related]
28. [Clinical features in DLBCL and translocation BCL2/c-MYC "double hit" lymphoma].
Škunca Ž; Domimis M; Plninc-Peraica A; Jakšić B
Acta Med Croatica; 2014 Jun; 68(3):299-305. PubMed ID: 26016222
[TBL] [Abstract][Full Text] [Related]
29. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
[TBL] [Abstract][Full Text] [Related]
30. Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases.
Soon G; Ow GW; Chan HL; Ng SB; Wang S
Ann Diagn Pathol; 2016 Oct; 24():40-6. PubMed ID: 27649953
[TBL] [Abstract][Full Text] [Related]
31. HIV-associated DLBCL: Clinicopathological factors including dual-colour chromogenic in situ hybridisation to assess MYC gene copies.
Pather S; Patel M
Ann Diagn Pathol; 2022 Jun; 58():151913. PubMed ID: 35299080
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
El Hussein S; Medeiros LJ; Lyapichev KA; Fang H; Jelloul FZ; Fiskus W; Chen J; Wei P; Schlette E; Xu J; Li S; Kanagal-Shamanna R; Yang H; Tang Z; Thakral B; Loghavi S; Jain N; Thompson PA; Ferrajoli A; Wierda WG; Jabbour E; Patel KP; Dabaja BS; Bhalla KN; Khoury JD
Pathology; 2023 Jun; 55(4):514-524. PubMed ID: 36933995
[TBL] [Abstract][Full Text] [Related]
33. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
[TBL] [Abstract][Full Text] [Related]
34. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors.
Na HY; Choe JY; Shin SA; Kim HJ; Han JH; Kim HK; Oh SH; Kim JE
PLoS One; 2019; 14(10):e0224247. PubMed ID: 31644584
[TBL] [Abstract][Full Text] [Related]
36. MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL.
Shi QY; Feng X; Bao W; Ma J; Lv JH; Wang X; Rao Q; Shi QL
J Neuropathol Exp Neurol; 2017 Nov; 76(11):942-948. PubMed ID: 29044419
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and genetic characteristics of diffuse large B-cell lymphoma of the oropharyngeal and maxillofacial region.
Xia S; Yue J; Chen X; Hu Y; Guo F; Zhang J
Oral Dis; 2021 Apr; 27(3):448-456. PubMed ID: 32731312
[TBL] [Abstract][Full Text] [Related]
38. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
Wang W; Hu S; Lu X; Young KH; Medeiros LJ
Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
[TBL] [Abstract][Full Text] [Related]
40. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
